OUR FACILITIES
cGMP Manufacturing
(Ansan Plant)
Where the CDMO legacy began: Established in 1998, Yuhan’s Ansan Plant has supported the success of numerous blockbuster, life-saving drugs. Built on decades of GMP expertise, the facility offers flexible multipurpose API and Intermediate manufacturing with proven quality and regulatory compliance. Today, it continues to serve global partners with reliable supply and scalable capabilities across the drug lifecycle.
  • icon
    Total Site Area
    31,598 ㎡
  • icon
    Total Reactor Capacity
    462,700 L
  • icon
    Established
    1998
  • icon
    Containment Level
    OEB 4 (~1 µg/m³)
OUR FACILITY
Interactive Site Map
Explore the Ansan plant, a key hub in Yuhan’s global CDMO operations.
Hover over each building to learn more about its function and capabilities.
icon Hover over a building to view details.
Production Bldg. A
  • icon
    Capacity
    101.0 ㎥
Production Bldg. B
  • icon
    Capacity
    43.7 ㎥
QC API
QA
MSAT
General Warehouse
Production Bldg. F
  • icon
    Capacity
    80.5 ㎥
General Administration
Production Bldg. G
  • icon
    Capacity
    237.5 ㎥
QC RM
Solvent Tank Farm
YUHAN CDMO
Plant Overview
From development to manufacturing, we bring experience, rigor, and collaboration to every step.
  • icon
    01 / Scale-up
    Seamless Scale-up from Development
    Development and manufacturing teams work within one organization, and technology transfer is carried out on site with the development team directly involved. Process knowledge from the lab is applied to the first commercial campaign.
  • icon
    02 / Supply
    Dependable commercial manufacturing
    Commercial programs are supported by consistent yields, robust production timelines, and continuous process improvement over the life of each product.
  • icon
    03 / Quality
    Built for Global Compliance
    Quality is our highest priority. The site operates under cGMP and is approved by the US FDA, Japan PMDA, Australia TGA, and Korea MFDS.
  • icon
    04 / Responsibility
    Safe and responsible operations
    Our ESG commitments include an EcoVadis Platinum rating, membership in the Pharmaceutical Supply Chain Initiative (PSCI), participation in the UN Global Compact, and a commitment to the Science Based Targets initiative (SBTi).
TRUSTED WORLDWIDE
Regulatory Track Records
Inspected by the FDA, MFDS, PMDA and TGA since 2002 with no major observations
  • icon
    US FDA
    FOOD AND DRUG
    ADMINISTRATION
    Since 2002
  • icon
    Australia TGA
    THERAPEUTIC GOODS
    ADMINISTRATION
    Since 2004
  • icon
    Japan PMDA
    PHARMACEUTICALS AND
    MEDICAL DEVICES AGENCY
    Since 2006
  • icon
    Korea MFDS
    MINISTRY OF FOOD
    AND DRUG SAFETY
    Since 1999
OUR LOCATION
Location
Strategically located 55km (34 miles) from Incheon International Airport.